// App-Quantinova.ai

1217-105 : WARFARIN FOR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION: COMPARISON OF PATIENT CHARACTERISTICS AND OUTCOMES OF THE REAL-WORLD MICHIGAN ANTICOAGULATION QUALITY IMPROVEMENT INITIATIVE (MAQI2) REGISTRY TO THE RE-LY, ROCKET-AF, AND ARISTOTLE TRIALS

Researchers

Presenter

  • Andrew Hughey

Principal Investigators

  • Geoffrey Barnes

  • Xiaokui Gu

  • James Froehlich

  • Brian Haymart

  • Eva Kline-Rogers

  • Steven Almany

  • Jay Kozlowski

  • Dennis Besley

  • Gregory D. Krol

  • Syed Ahsan

  • Scott Kaatz

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Myocardial infarction

  • Arrhythmia

  • Venous thrombosis

  • Congestive heart failure

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Warfarin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved